Year : 2019 | Volume
: 22 | Issue : 2 | Page : 131--136
Can we treat secondary progressive multiple sclerosis now?
Rohit Bhatia, Nishita Singh
Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
Secondary progressive multiple sclerosis (SPMS) is characterized by progressive accumulation of disability without intermittent recovery. Treatment of these patients is challenging due to limited understanding of pathogenesis and fewer therapeutic options. This article summarizes difficulties in defining and conducting trials in SPMS, review major clinical trials on therapies approved and unapproved in SPMS and lastly, therapies in pipeline for use in SPMS.
Dr. Rohit Bhatia
Department of Neurology, Neurosciences Centre, All India Institute of Medical Sciences, New Delhi - 110 029
|How to cite this article:|
Bhatia R, Singh N. Can we treat secondary progressive multiple sclerosis now?.Ann Indian Acad Neurol 2019;22:131-136
|How to cite this URL:|
Bhatia R, Singh N. Can we treat secondary progressive multiple sclerosis now?. Ann Indian Acad Neurol [serial online] 2019 [cited 2019 Aug 25 ];22:131-136
Available from: http://www.annalsofian.org/article.asp?issn=0972-2327;year=2019;volume=22;issue=2;spage=131;epage=136;aulast=Bhatia;type=0